Prof. Lavrencij Stanovnik was the President of the Organising Committee. Prof. Tatjana Irman-Florjanc was the President of the Scientific Committee: prof. Tatjana Irman-Florjanc At the congress, there were more than 100 participants from the Europe, USA, Japan and Argentina, with 71 scientific presentations. Prof. Marija Čarman Kržan gave an invited lecture, whereas the investigators from our research group (P3-067) contributed with 10 presentation, and two of them were awarded for the best poster prices of the congres. We published the book of abstracts.
B.01 Organiser of a scientific meeting
COBISS.SI-ID: 219879936Application to the FP-HEALTH-2007B; Proposal No:223-619. Proposal Neuroprotective Approaches for the Treatment of Alzheimer Disease.Partner: Metoda Lipnik-Štangelj (Slovenia)- BI-SLO-SCG/05-06-11: Characterisation of olive oil; BI-SLO-CRO 35/03-04 ext 2005: Pharmacology of the cardiovascular system J4-6030: Characterisation of c. v. Istrska belica; Z-7212:Development of an identification system of fig varieties by means of DNA markers; J3-0024: Pharmacological protection against ishemic-reperfusion damage and degenerative processes in the brain and cardiovascular tissue.
D.01 Chairing over/coordinating (international and national) projects
COBISS.SI-ID: 00000000Metoda Lipnik-Štangelj - Delegate of R Slovenia in the CHMP (Scientific Commitee for Human Medicinal Products) at the European Drug Agency (EMEA); first mandate: from 2004 to 2007, second mandate: 2007 - 2010 (nominated by Minister for Health,R Slovenia) Metoda Lipnik-Štangelj coordinated the centralised procedure of the marketing autorisation of first generic drug (Zalasta, olanzapine, Krka d.d.Novo mesto) in the EU as Rapporteur. Since this was the first generic aplication, SOP and Guidlines for the generic dug assessment were prepared as well.
D.03 Membership in foreign/international boards/committees
COBISS.SI-ID: 00000000Katarina Černe - Delegate of R Slovenia in OECD (International Organisation for Economic Collaboration and Development) since 2002 (nominated by Minister for Economy, R Slovenia). Katarina Černe is a member of the Working party for development of the guidelines for chemical testing. She is also involved in the harmonisation and implementation of guidelines in R Slovenia.
D.03 Membership in foreign/international boards/committees
COBISS.SI-ID: 23682521Tatjana Irman-Florjanc - member of the steering committee of European Histamine research Society from 2004-2006.
D.03 Membership in foreign/international boards/committees
COBISS.SI-ID: 00000000Application to the FP-HEALTH-2007B; Proposal No:223-619. Proposal Neuroprotective Approaches for the Treatment of Alzheimer Disease.Partner: Metoda Lipnik-Štangelj (Slovenia)- BI-SLO-SCG/05-06-11: Characterisation of olive oil; BI-SLO-CRO 35/03-04 ext 2005: Pharmacology of the cardiovascular system J4-6030: Characterisation of c. v. Istrska belica; Z-7212:Development of an identification system of fig varieties by means of DNA markers; J3-0024: Pharmacological protection against ishemic-reperfusion damage and degenerative processes in the brain and cardiovascular tissue.
D.01 Chairing over/coordinating (international and national) projects
Prof. Lavrencij Stanovnik was the President of the Organising Committee. Prof. Tatjana Irman-Florjanc was the President of the Scientific Committee: prof. Tatjana Irman-Florjanc At the congress, there were more than 100 participants from the Europe, USA, Japan and Argentina, with 71 scientific presentations. Prof. Marija Čarman Kržan gave an invited lecture, whereas the investigators from our research group (P3-067) contributed with 10 presentation, and two of them were awarded for the best poster prices of the congres. We published the book of abstracts.
B.01 Organiser of a scientific meeting
Metoda Lipnik-Štangelj - Delegate of R Slovenia in the CHMP (Scientific Commitee for Human Medicinal Products) at the European Drug Agency (EMEA); first mandate: from 2004 to 2007, second mandate: 2007 - 2010 (nominated by Minister for Health,R Slovenia) Metoda Lipnik-Štangelj coordinated the centralised procedure of the marketing autorisation of first generic drug (Zalasta, olanzapine, Krka d.d.Novo mesto) in the EU as Rapporteur. Since this was the first generic aplication, SOP and Guidlines for the generic dug assessment were prepared as well.
D.03 Membership in foreign/international boards/committees
Tatjana Irman-Florjanc - member of the steering committee of European Histamine research Society from 2004-2006.
D.03 Membership in foreign/international boards/committees